YU47594B - KRISTALNA SO (4-DI-N-PROPIL)AMINO-6-AMINOKARBONIL-1,3,4,5-TETRAHIDROBENZ/cd/INDOLA I POSTUPAK ZA NJENO DOBIJANJE - Google Patents

KRISTALNA SO (4-DI-N-PROPIL)AMINO-6-AMINOKARBONIL-1,3,4,5-TETRAHIDROBENZ/cd/INDOLA I POSTUPAK ZA NJENO DOBIJANJE

Info

Publication number
YU47594B
YU47594B YU32791A YU32791A YU47594B YU 47594 B YU47594 B YU 47594B YU 32791 A YU32791 A YU 32791A YU 32791 A YU32791 A YU 32791A YU 47594 B YU47594 B YU 47594B
Authority
YU
Yugoslavia
Prior art keywords
indola
aminocarbonyl
propyl
amino
obtaining
Prior art date
Application number
YU32791A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU32791A (sh
Inventor
T.J. Kress
D.L. Varie
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU32791A publication Critical patent/YU32791A/sh
Publication of YU47594B publication Critical patent/YU47594B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU32791A 1990-02-26 1991-02-25 KRISTALNA SO (4-DI-N-PROPIL)AMINO-6-AMINOKARBONIL-1,3,4,5-TETRAHIDROBENZ/cd/INDOLA I POSTUPAK ZA NJENO DOBIJANJE YU47594B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48518590A 1990-02-26 1990-02-26

Publications (2)

Publication Number Publication Date
YU32791A YU32791A (sh) 1994-01-20
YU47594B true YU47594B (sh) 1995-10-24

Family

ID=23927224

Family Applications (1)

Application Number Title Priority Date Filing Date
YU32791A YU47594B (sh) 1990-02-26 1991-02-25 KRISTALNA SO (4-DI-N-PROPIL)AMINO-6-AMINOKARBONIL-1,3,4,5-TETRAHIDROBENZ/cd/INDOLA I POSTUPAK ZA NJENO DOBIJANJE

Country Status (28)

Country Link
US (1) US5397799A (OSRAM)
EP (1) EP0444852B1 (OSRAM)
JP (1) JP3157007B2 (OSRAM)
KR (1) KR100208114B1 (OSRAM)
CN (1) CN1027503C (OSRAM)
AT (1) ATE126506T1 (OSRAM)
AU (1) AU629453B2 (OSRAM)
BR (1) BR9100767A (OSRAM)
CA (1) CA2037099C (OSRAM)
CY (1) CY1887A (OSRAM)
DE (1) DE69112099T2 (OSRAM)
DK (1) DK0444852T3 (OSRAM)
ES (1) ES2077796T3 (OSRAM)
FI (1) FI95464C (OSRAM)
GR (1) GR3017940T3 (OSRAM)
HK (1) HK175495A (OSRAM)
HU (1) HU217118B (OSRAM)
IE (1) IE67801B1 (OSRAM)
IL (1) IL97306A (OSRAM)
LV (1) LV10251B (OSRAM)
NO (1) NO174149C (OSRAM)
NZ (1) NZ237181A (OSRAM)
PT (1) PT96852B (OSRAM)
RU (2) RU2034837C1 (OSRAM)
SG (1) SG69975A1 (OSRAM)
TW (1) TW219933B (OSRAM)
YU (1) YU47594B (OSRAM)
ZA (1) ZA911258B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli 6-Substituted-hexahydrobenz (cd) indoles process for their preparation and pharmaceutical compositions containing them
IL97309A (en) * 1990-02-26 1996-11-14 Lilly Co Eli Intermediates for hexahydrobenz Úcd¾ indoles and process for the preparation of pure enantiomers thereof
US5627199A (en) * 1991-03-28 1997-05-06 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz [CD] indoles
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
TW248556B (OSRAM) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
UA53205C2 (en) * 2002-04-03 2006-06-15 Pharmatech Close Joint Stock C Antidepressant formulation and method for its manufacture
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
DK3357911T3 (da) 2006-06-26 2022-07-04 Akebia Therapeutics Inc Prolylhydroxylaseinhibitorer og fremgangsmåder til anvendelse
PT2496084E (pt) * 2009-11-06 2015-08-21 Aerpio Therapeutics Inc Métodos para aumentar a estabilização de fator-1 alfa indutivel por hipoxia
NO2686520T3 (OSRAM) 2011-06-06 2018-03-17
JP2014522410A (ja) 2011-06-06 2014-09-04 アケビア セラピューティクス インコーポレイテッド がん治療のための方法として低酸素誘導因子−２αを安定化するための、化合物および組成物
MY204336A (en) 2013-06-13 2024-08-23 Akebia Therapeutics Inc Compositions and methods for treating anemia
EP3578546A1 (en) 2013-11-15 2019-12-11 Akebia Therapeutics Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
AU2016209126A1 (en) 2015-01-23 2017-08-10 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
BR112017021097B1 (pt) 2015-04-01 2024-01-02 Akebia Therapeutics, Inc Formulação de dosagem oral e seu uso
MX2020011845A (es) 2018-05-09 2021-01-15 Akebia Therapeutics Inc Proceso para preparar acido 2-[[5-(3-clorofenil)-3-hidroxipiridina -2-carbonil]amino]acetico.
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles

Also Published As

Publication number Publication date
FI910895L (fi) 1991-08-27
DE69112099T2 (de) 1996-02-08
CA2037099C (en) 2001-09-11
EP0444852A2 (en) 1991-09-04
FI95464B (fi) 1995-10-31
NO910735D0 (no) 1991-02-25
DK0444852T3 (da) 1995-12-11
PT96852B (pt) 1998-07-31
HK175495A (en) 1995-11-24
FI910895A0 (fi) 1991-02-25
TW219933B (OSRAM) 1994-02-01
ATE126506T1 (de) 1995-09-15
CA2037099A1 (en) 1991-08-27
IE67801B1 (en) 1996-05-01
HU217118B (hu) 1999-11-29
LV10251B (en) 1995-04-20
LV10251A (lv) 1994-10-20
SG69975A1 (en) 2000-01-25
NO910735L (no) 1991-08-27
IE910625A1 (en) 1991-08-28
NZ237181A (en) 1992-06-25
AU629453B2 (en) 1992-10-01
JP3157007B2 (ja) 2001-04-16
CN1027503C (zh) 1995-01-25
FI95464C (fi) 1996-02-12
CN1054589A (zh) 1991-09-18
AU7197191A (en) 1991-08-29
PT96852A (pt) 1991-10-31
ZA911258B (en) 1992-10-28
EP0444852B1 (en) 1995-08-16
BR9100767A (pt) 1991-10-29
ES2077796T3 (es) 1995-12-01
US5397799A (en) 1995-03-14
GR3017940T3 (en) 1996-02-29
KR910021375A (ko) 1991-12-20
CY1887A (en) 1996-04-05
NO174149C (no) 1994-03-23
IL97306A0 (en) 1992-05-25
DE69112099D1 (de) 1995-09-21
NO174149B (no) 1993-12-13
YU32791A (sh) 1994-01-20
EP0444852A3 (en) 1992-02-19
RU2083561C1 (ru) 1997-07-10
JPH04217662A (ja) 1992-08-07
KR100208114B1 (ko) 1999-07-15
IL97306A (en) 1996-10-16
HUT56542A (en) 1991-09-30
RU2034837C1 (ru) 1995-05-10

Similar Documents

Publication Publication Date Title
YU47594B (sh) KRISTALNA SO (4-DI-N-PROPIL)AMINO-6-AMINOKARBONIL-1,3,4,5-TETRAHIDROBENZ/cd/INDOLA I POSTUPAK ZA NJENO DOBIJANJE
RU94036004A (ru) Промежуточные соединения для получения ароматических аминоспиртовых производных
ATE114151T1 (de) Benzocyclobutyl- oder indanyl-alkyl-amino-alkyl substituierte 3-benzazepin-2-ones, verwendbar in der behandlung von kardiovaskularen krankheiten.
MY131298A (en) 5-heteroyl indole derivatives
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
NO905608L (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
DE69528273D1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
NO924433L (no) Isoksazol-4-karboksylsyreamider og hydroksyalkyliden-cyaneddiksyreamider, legemidler inneholdende disse forbindelsene og deres anvendelse
NO914092D0 (no) Fremgangsmaate for fremstilling av mercaptoacetylamidderivater
NO304186B1 (no) 1H-indol-3-glykosylamid og farmas°ytisk formulering
DE10075033I2 (de) substituierte Pyrazolyl-benzolsulfonamide zur Behandlung von Entzündungen.
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
DK0533824T3 (da) Piperidylsubstituerede indoler
AU3582095A (en) Isothiourea derivatives as no synthase inhibitors
ATE222492T1 (de) Verwendung von indolderivaten als 5ht1-agonisten
ATE81976T1 (de) 2-pyrimidinyl-1-piperazin-derivate zur behandlung von alkoholismus.
NO175098C (no) Analogifremgangsmåte for fremstilling av substituerte indoler
DK23392D0 (da) Heterocykliske forbindelser, deres anvendelse og fremstilling
FI914715A0 (fi) Anvaendning av fosfonsyradiglycidylestrar som foernaetningsmedel vid framstaellning av hydrogel.
PT89029A (pt) Processo para a preparacao de novos derivados substituidos de 20,21-dinoreburnamenina
EA199900710A1 (ru) Кристаллическая гидратированная натриевая соль (е)-4,6-дихлор-3-(2-оксо-1-фенилпирролидин-3-илиденметил)-1н-индол-2-карбоновой кислоты
FI880385A0 (fi) Substituerade 3-fenyl-7h-tiazolo /3,2-b//1,2,4/-triazin-7-oner, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning, samt naogra vid framstaellningen av naemnda foereningar bildade mellanprodukter.
YU46150B (sh) Racemski i optički aktivni derivati 14-hidrpksi-imino-eburnana kao i postupak za njihovo dobijanje
HUT36117A (en) Process for preparing indolo/2,3-a/quinolizine-oxime esters